I guess the strategy was to volume fill the pipeline (hence significant sales revenue) and build on that. I think you need to remember the company has never published expected targets but more a steady increase in distribution via Frostbland who have distribution and revenue commitments to CDY. In my view, it is too early to cast aspersions but I would be looking for a significant sales uplift in the next quarter especially with the recruitment of a VP with the charter on building growth with the Evolis brand. I would be disappointed if sales weren't plus $1M for a 12 month trading period.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
I guess the strategy was to volume fill the pipeline (hence...
Featured News
Add AN1 (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $69 | 9.915K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 214856 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 280000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 214856 | 0.007 |
4 | 2016527 | 0.006 |
1 | 300000 | 0.005 |
2 | 525000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.013 | 750000 | 1 |
0.015 | 340000 | 2 |
0.022 | 4000 | 1 |
Last trade - 09.59am 29/07/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |